Report cover image

Europe Drug modeling software Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 276 Pages
SKU # DAABD18055160

Description

Europe Drug modeling software Market - Industry Trends and Forecast to 2030


The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.

Market Segmentation:
Europe Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country (Germany, France , U.K., Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium,Poland, Sweden, Denmark, Finland, Norway, Rest of Europe)- Industry Trends and Forecast to 2030

Overview of Drug Modeling Software Market Dynamics:

Driver
• Rising drug discovery and development activities

Restrain

• Lack of quality data base

Opportunity

• Cloud computing and big data analytics in drug modelling

Market Players:

The key market players operating in the drug modeling software market are listed below:

• Dotmatics
• BC Platforms
• InSilicoTrials Technologies.
• VeriSIM Life., Atomwise Inc.
• Certara, USA.
• GENECODE
• Cresset., and Nanome Inc.
• SIMULATIONS PLUS.
• Dassault Systèmes
• Scripps Research
• XtalPi Inc.
• Xybion
• ArgusLab
• Schrödinger, Inc.

Table of Contents

276 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Drug Modeling Software Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modeling
2.7 Component Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market Application Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
3.1 Porter's Five Forces Model
3.2 Value Chain Analysis
3.3 Regulatory Standards
3.4 Technological Trends
3.5 Benefits Of Drug Modeling Software
4 Market Overview
4.1 Drivers
4.1.1 Rising Drug Discovery And Development Activities
4.1.2 Rising Demand For Novel Therapies
4.1.3 Precision Medicine And Intervention Of Ai In Drug Modelling
4.2 Restraints
4.2.1 Lack Of Quality Data Base
4.2.2 High Cost Of Manufacturing Of Drug Modelling Software
4.3 Opportunities
4.3.1 Cloud Computing And Big Data Analytics In Drug Modelling
4.3.2 Increasing Adoption Of Modelling Tools In Drug Discovery
4.4 Challenges
4.4.1 Lack Of Procedure For Multi-drug Effect Assesment
4.4.2 Challenges With Model Interpretation
5 Europe Drug Modeling Software Market, By Components
5.1 Overview
5.1.1 Software
5.1.1.1 Integrated
5.1.1.2 Standalone
5.1.1.3 Ligand Based
5.1.1.4 Structure Based
5.2 Services
5.2.1 Professional Services
5.2.1.1 Consulting And Training
5.2.1.2 Integration And Implementation
5.2.1.3 Support And Maintenance
5.2.2 Managed Services
6 Europe Drug Modeling Software Market, By Operating System
6.1 Overview
6.2 Windows
6.3 Linux
6.4 Mac Os
6.5 Others
7 Europe Drug Modeling Software Market, By Deployment Mode
7.1 Overview
7.2 Cloud Based
7.3 Hybrid-based
7.4 On-premises
8 Europe Drug Modeling Software Market, By Enterprise Size
8.1 Overview
8.2 Large Enterprise Size
8.3 Small & Medium Enterprise Size
9 Europe Drug Modeling Software Market, By Application
9.1 Overview
9.2 Graphical Molecular Modeling
9.3 Gene Sequence Analysis
9.4 Protein Modeling
9.5 Modeling Crystal Structures
9.6 Cheminformatics
9.7 High Throughput Virtual Screening
9.8 Gas & Solution Phase Reaction
9.9 Medical Imaging
9.10 Others
10 Europe Drug Modeling Software Market, By Purchasing Model
10.1 Overview
10.2 Subscription Based
10.2.1 Annually Subscription
10.2.2 Monthly Subscription
10.3 One-time License
10.3.1 Group License
10.3.2 Desktop License
10.3.3 Others
11 Europe Drug Modeling Software Market, By End User
11.1 Overview
11.2 Pharmaceutical & Biotechnology Companies
11.2.1 Large Enterprise Size
11.2.2 Small & Medium Enterprise Size
11.3 Contract Research Organizations
11.3.1 Large Enterprise Size
11.3.2 Small & Medium Enterprise Size
11.4 Research Institutes
11.4.1 Large Enterprise Size
11.4.2 Small & Medium Enterprise Size
11.5 Regulatory Authorities
11.5.1 Large Enterprise Size
11.5.2 Small & Medium Enterprise Size
11.6 Others
11.6.1 Large Enterprise Size
11.6.2 Small & Medium Enterprise Size
12 Europe Drug Modeling Software Market, By Region
12.1 Europe
12.1.1 Germany
12.1.2 France
12.1.3 U.K.
12.1.4 Italy
12.1.5 Russia
12.1.6 Spain
12.1.7 Turkey
12.1.8 Netherlands
12.1.9 Switzerland
12.1.10 Belgium
12.1.11 Poland
12.1.12 Sweden
12.1.13 Denmark
12.1.14 Finland
12.1.15 Norway
12.1.16 Rest Of Europe
13 Europe Drug Modeling Software Market: Company Landscape
13.1 Company Share Analysis: Europe
14 Swot Analysis
15 Europe Drug Modeling Software Market, Company Profile
15.1 Dassault Systemes
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Amazon Web Services, Inc. Or Its Affiliates.(A Subsidiary Of Amazon)
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Developments
15.3 Certara, Usa.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Schrödinger, Inc.
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Cresset.
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Developments
15.6 Acellera Ltd
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Developments
15.7 Arguslab
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Atomwise Inc.
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Bc Platforms
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Developments
15.10 Biosolveit Gmbh
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Development
15.11 Dotmatics
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Developments
15.12 Genecode
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Insilicotrials Technologies.
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Developments
15.14 Nanome Inc.
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Optibrium, Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Pharmacelera
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Simulations Plus.
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Company Share Analysis
15.17.4 Product Portfolio
15.17.5 Recent Development
15.18 The Scripps Research Institute
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Verisim Life.
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Developments
15.20 Xtalpi Inc.
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
15.21 Xybion Digital Inc.
15.21.1 Company Snapshot
15.21.2 Revenue Analysis
15.21.3 Product Portfolio
15.21.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables
Table 1 Europe Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 2 Europe Softaware In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 3 Europe Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 4 Europe Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 5 Europe Services In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 6 Europe Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 7 Europe Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 8 Europe Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 9 Europe Windows In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 10 Europe Linux In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 11 Europe Mac Os In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 13 Europe Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 14 Europe Cloud Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Hybrid-based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 16 Europe On-premises In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 17 Europe Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 18 Europe Large Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 19 Europe Small & Medium Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 21 Europe Graphical Molecular Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Gene Sequence Analysis In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Protein Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Modeling Crystal Structures In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Cheminformatics In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe High Throughput Virtual Screening In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 27 Europe Gas & Solution Phase Reaction In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Medical Imaging In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 30 Europe Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 31 Europe Subscription Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 33 Europe One-time License In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 34 Europe One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 35 Europe Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 36 Europe Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 37 Europe Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 38 Europe Contract Research Organizations In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 39 Europe Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 40 Europe Research Institutes In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 41 Europe Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 42 Europe Regulatory Authorities In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 43 Europe Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 44 Europe Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million)
Table 45 Europe Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 46 Europe Drug Modeling Software Market, By Country, 2021-2030 (Usd Million)
Table 47 Europe Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 48 Europe Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 49 Europe Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 50 Europe Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 51 Europe Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 52 Europe Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 53 Europe Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 54 Europe Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 55 Europe Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 56 Europe Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 57 Europe Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 58 Europe One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 59 Europe Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 60 Europe Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 61 Europe Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 62 Europe Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 63 Europe Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 64 Europe Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 65 Germany Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 66 Germany Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 67 Germany Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 68 Germany Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 69 Germany Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 70 Germany Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 71 Germany Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 72 Germany Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 73 Germany Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 74 Germany Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 75 Germany Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 76 Germany One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 77 Germany Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 78 Germany Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 79 Germany Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 80 Germany Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 81 Germany Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 82 Germany Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 83 France Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 84 France Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 85 France Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 86 France Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 87 France Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 88 France Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 89 France Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 90 France Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 91 France Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 92 France Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 93 France Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 94 France One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 95 France Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 96 France Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 97 France Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 98 France Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 99 France Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 100 France Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 101 U.K. Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 102 U.K. Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 103 U.K. Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 104 U.K. Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 105 U.K. Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 106 U.K. Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 107 U.K. Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 108 U.K. Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 109 U.K. Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 110 U.K. Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 111 U.K. Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 112 U.K. One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 113 U.K. Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 114 U.K. Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 115 U.K. Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 116 U.K. Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 117 U.K. Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 118 U.K. Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 119 Italy Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 120 Italy Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 121 Italy Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 122 Italy Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 123 Italy Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 124 Italy Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 125 Italy Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 126 Italy Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 127 Italy Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 128 Italy Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 129 Italy Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 130 Italy One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 131 Italy Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
Table 132 Italy Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 133 Italy Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 134 Italy Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 135 Italy Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 136 Italy Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 137 Russia Drug Modeling Software Market, By Components, 2021-2030 (Usd Million)
Table 138 Russia Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million)
Table 139 Russia Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 140 Russia Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 141 Russia Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million)
Table 142 Russia Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million)
Table 143 Russia Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million)
Table 144 Russia Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
Table 145 Russia Drug Modeling Software Market, By Application, 2021-2030 (Usd Million)
Table 146 Russia Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 147 Russia Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 148 Russia One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million)
Table 149 Russia Drug Modeling Software Market, By End User, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Drug Modeling Software Market: Segmentation
Figure 2 Europe Drug Modeling Software Market: Data Triangulation
Figure 3 Europe Drug Modeling Software Market: Droc Analysis
Figure 4 Europe Drug Modeling Software Market: Europe Vs. Regional Market Analysis
Figure 5 Europe Drug Modeling Software Market: Company Research Analysis
Figure 6 Europe Drug Modeling Software Market: Interview Demographics
Figure 7 Europe Drug Modeling Software Market: Multivariate Modeling
Figure 8 Europe Drug Modeling Software Market: Dbmr Market Position Grid
Figure 9 Europe Drug Modeling Software Market: Vendor Share Analysis
Figure 10 Europe Drug Modeling Software Market: Market Application Coverage Grid
Figure 11 Europe Drug Modeling Software Market: Segmentation
Figure 12 Rising Drug Discovery And Development Activities, Rising Demand For Novel Therapies, And Precision Medicine And Intervention Of Ai In Drug Modelling Are Are Expected To Drive The Europe Drug Modeling Software Market Growth In The Forecast Period From 2023 To 2030
Figure 13 Software Segment Is Expected To Account For The Largest Share Of The Europe Drug Modeling Software Market In 2023 & 2030
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Europe Drug Modeling Software Market
Figure 15 Europe Drug Modeling Software Market: By Components, 2022
Figure 16 Europe Drug Modeling Software Market: By Components, 2023-2030 (Usd Million)
Figure 17 Europe Drug Modeling Software Market: By Components, Cagr (2023-2030)
Figure 18 Europe Drug Modeling Software Market: By Components, Lifeline Curve
Figure 19 Europe Drug Modeling Software Market: By Operating System, 2022
Figure 20 Europe Drug Modeling Software Market: By Operating System, 2023-2030 (Usd Million)
Figure 21 Europe Drug Modeling Software Market: By Operating System, Cagr (2023-2030)
Figure 22 Europe Drug Modeling Software Market: By Operating System, Lifeline Curve
Figure 23 Europe Drug Modeling Software Market: By Deployment Mode, 2022
Figure 24 Europe Drug Modeling Software Market: By Deployment Mode, 2023-2030 (Usd Million)
Figure 25 Europe Drug Modeling Software Market: By Deployment Mode, Cagr (2023-2030)
Figure 26 Europe Drug Modeling Software Market: By Deployment Mode, Lifeline Curve
Figure 27 Europe Drug Modeling Software Market: By Enterprise Size, 2022
Figure 28 Europe Drug Modeling Software Market: By Enterprise Size, 2023-2030 (Usd Million)
Figure 29 Europe Drug Modeling Software Market: By Enterprise Size, Cagr (2023-2030)
Figure 30 Europe Drug Modeling Software Market: By Enterprise Size, Lifeline Curve
Figure 31 Europe Drug Modeling Software Market: By Application, 2022
Figure 32 Europe Drug Modeling Software Market: By Application, 2023-2030 (Usd Million)
Figure 33 Europe Drug Modeling Software Market: By Application, Cagr (2023-2030)
Figure 34 Europe Drug Modeling Software Market: By Application, Lifeline Curve
Figure 35 Europe Drug Modeling Software Market: By Purchasing Model, 2022
Figure 36 Europe Drug Modeling Software Market: By Purchasing Model, 2023-2030 (Usd Million)
Figure 37 Europe Drug Modeling Software Market: By Purchasing Model, Cagr (2023-2030)
Figure 38 Europe Drug Modeling Software Market: By Purchasing Model, Lifeline Curve
Figure 39 Europe Drug Modeling Software Market: By End User, 2022
Figure 40 Europe Drug Modeling Software Market: By End User, 2023-2030 (Usd Million)
Figure 41 Europe Drug Modeling Software Market: By End User, Cagr (2023-2030)
Figure 42 Europe Drug Modeling Software Market: By End User, Lifeline Curve
Figure 43 Europe Drug Modeling Software Market: Snapshot (2022)
Figure 44 Europe Drug Modeling Software Market: By Country (2022)
Figure 45 Europe Drug Modeling Software Market: By Country (2023 & 2030)
Figure 46 Europe Drug Modeling Software Market: By Country (2022 & 2030)
Figure 47 Europe Drug Modeling Software Market: By Components (2023-2030)
Figure 48 Europe Drug Modeling Software Market: Company Share 2022 (%) 208

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us